Evidence map›Paper›PMID 38741765›Full record

ArticleFrontiers in medicine2024

Lung function benefits of traditional Chinese medicine Qiju granules against fine particulate air pollution exposure: a randomized controlled trial.

Rucheng Chen, Lu Zhang, Weijia Gu, Ran Li, Huihua Hong, Linshui Zhou, Jinna Zhang, Yixuan Wang, Ping Ni, Shuqin Xu and 4 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Air pollution-induced airway epithelial barrier dysfunction in COPD: a narrative review of mechanisms and therapeutic implications.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rucheng Chen *School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Lu Zhang *School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Weijia GuSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Ran LiSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Huihua HongFirst Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Linshui ZhouFirst Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Jinna ZhangSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Yixuan WangSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Ping NiFirst Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Shuqin XuFirst Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Zhen WangFirst Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Qinghua SunSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Cuiqing LiuSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Junchao YangFirst Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multiple targets are considered as the causes of ambient fine particulate matter [aerodynamic diameters of < 2.5 μm (PM Methods: A randomized, double-blinded, and placebo-controlled trial was performed among 47 healthy college students in Hangzhou, Zhejiang Province in China. The participants were randomly assigned to the Qiju granules group or the control group based on gender. Clinical follow-ups were conducted once every 2 weeks during a total of 4 weeks of intervention. Real-time monitoring of PM Results: In total, 40 eligible participants completed the scheduled follow-ups. The average PM Conclusion: The results of the study showed that PM Clinical Trial Registration: identifier: ChiCTR1900021235.

Indexed as

clinical trialfine particulate matterlung functionQiju granulestraditional Chinese medicine

Identifiers

PMID38741765
PMCPMC11089203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.